These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7541419)

  • 1. Identification of complement regulatory domains in human factor H.
    Gordon DL; Kaufman RM; Blackmore TK; Kwong J; Lublin DM
    J Immunol; 1995 Jul; 155(1):348-56. PubMed ID: 7541419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
    Iwata K; Seya T; Yanagi Y; Pesando JM; Johnson PM; Okabe M; Ueda S; Ariga H; Nagasawa S
    J Biol Chem; 1995 Jun; 270(25):15148-52. PubMed ID: 7541036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.
    Coyne KE; Hall SE; Thompson S; Arce MA; Kinoshita T; Fujita T; Anstee DJ; Rosse W; Lublin DM
    J Immunol; 1992 Nov; 149(9):2906-13. PubMed ID: 1383332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
    Barilla-LaBarca ML; Liszewski MK; Lambris JD; Hourcade D; Atkinson JP
    J Immunol; 2002 Jun; 168(12):6298-304. PubMed ID: 12055245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation.
    Christiansen D; Loveland B; Kyriakou P; Lanteri M; Rubinstein E; Gerlier D
    Mol Immunol; 2000; 37(12-13):687-96. PubMed ID: 11275254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).
    Reilly BD; Makrides SC; Ford PJ; Marsh HC; Mold C
    J Biol Chem; 1994 Mar; 269(10):7696-701. PubMed ID: 8125996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
    J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).
    Manchester M; Valsamakis A; Kaufman R; Liszewski MK; Alvarez J; Atkinson JP; Lublin DM; Oldstone MB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2303-7. PubMed ID: 7534417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.
    Makrides SC; Scesney SM; Ford PJ; Evans KS; Carson GR; Marsh HC
    J Biol Chem; 1992 Dec; 267(34):24754-61. PubMed ID: 1447213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).
    Giannakis E; Jokiranta TS; Ormsby RJ; Duthy TG; Male DA; Christiansen D; Fischetti VA; Bagley C; Loveland BE; Gordon DL
    J Immunol; 2002 May; 168(9):4585-92. PubMed ID: 11971006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
    Fukui A; Yuasa-Nakagawa T; Murakami Y; Funami K; Kishi N; Matsuda T; Fujita T; Seya T; Nagasawa S
    J Biochem; 2002 Nov; 132(5):719-28. PubMed ID: 12417021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity.
    Adams EM; Brown MC; Nunge M; Krych M; Atkinson JP
    J Immunol; 1991 Nov; 147(9):3005-11. PubMed ID: 1717583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chicken membrane-associated complement regulatory protein: molecular cloning and functional characterization.
    Inoue N; Fukui A; Nomura M; Matsumoto M; Nishizawa Y; Toyoshima K; Seya T
    J Immunol; 2001 Jan; 166(1):424-31. PubMed ID: 11123320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H.
    Blackmore TK; Sadlon TA; Ward HM; Lublin DM; Gordon DL
    J Immunol; 1996 Dec; 157(12):5422-7. PubMed ID: 8955190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor.
    Pham T; Kaul A; Hart A; Goluszko P; Moulds J; Nowicki S; Lublin DM; Nowicki BJ
    Infect Immun; 1995 May; 63(5):1663-8. PubMed ID: 7537246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
    Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
    J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities.
    Higgins PJ; Ko JL; Lobell R; Sardonini C; Alessi MK; Yeh CG
    J Immunol; 1997 Mar; 158(6):2872-81. PubMed ID: 9058824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
    Brodbeck WG; Mold C; Atkinson JP; Medof ME
    J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.